You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Myeloma Agents

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

Recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Manufactured Anti-BCMA CAR-T cells
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

Advanced Solid Tumor Trial (SHR-A1921;)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Feb 28, 2023

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
Feb 17, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and

Not yet recruiting
  • Disability or Chronic Disease Leading to Disablement
  • +2 more
  • Surgical flap and anti-bacterial agents
  • Garches, France
    Department of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023

Multiple Myeloma Trial in Philadelphia (CART-19 cells)

Terminated
Has Results
  • Multiple Myeloma
  • CART-19 cells
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 4, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Based on PRO Data Reported ThroughMHealth App Solution in

Completed
  • Multiple Myeloma
  • mHealth app
  • Odense, Denmark
    Odense University Hospital
Feb 10, 2023

Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

Recruiting
  • Solid Tumor
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Jun 14, 2023

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Multiple Myeloma Trial in Orange, Sacramento, Oklahoma City (STI-1492)

Recruiting
  • Multiple Myeloma
  • STI-1492
  • Orange, California
  • +2 more
Jan 12, 2023

Relapsed or Refractory Multiple Myeloma Trial in Beijing, Guangzhou, Hangzhou (STI-6129)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • STI-6129
  • Beijing, Beijing, China
  • +3 more
Jan 9, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)

Completed
  • Atherosclerosis
  • +2 more
  • Kumasi, Ghana
    Kwame Nkrumah University of Science & Technology
Sep 29, 2022

Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

Completed
  • Crohn's Disease
  • Ulcerative Colitis
  • Immuno monitoring
  • Montpellier, France
    University hospital
Dec 13, 2022

Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

Not yet recruiting
  • Ovarian Cancer
  • Lung Adenocarcinoma
  • Duarte, California
  • +6 more
Mar 21, 2023

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Nov 28, 2023

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • CB-011
  • New York, New York
  • +3 more
Feb 15, 2023